[Mucocutaneous leishmaniasis in Morocco, evidence of the parasite's ecological evolution?].
S
S
Iguermia
T
T
Harmouche
O
O
Mikou
A
A
Amarti
F Z
FZ
Mernissi
D000293:Adolescent; D000349:Africa; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D005075:Biological Evolution; D002613:Cheilitis / Q000188:drug therapy / Q000469:parasitology*; D006790:Host-Parasite Interactions; D006801:Humans; D007121:Immunocompetence; D007843:Latin America; D007891:Leishmania / Q000145:classification / Q000472:pathogenicity; D007892:Leishmania braziliensis / Q000472:pathogenicity* / Q000502:physiology; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009018:Morocco / Q000453:epidemiology; D009942:Organometallic Compounds / Q000627:therapeutic use; D013045:Species Specificity; D014774:Virulence
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate